Novartis AG (NVSEF)
104.15
0.00 (0.00%)
At close: Apr 11, 2025, 3:14 PM
0.00% (1D)
| Bid | 104.15 |
| Market Cap | 197.63B |
| Revenue (ttm) | 50.78B |
| Net Income (ttm) | 11.94B |
| EPS (ttm) | 5.87 |
| PE Ratio (ttm) | 17.74 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 116.1 |
| Volume | 612 |
| Avg. Volume (20D) | 92,167 |
| Open | 97.30 |
| Previous Close | 104.15 |
| Day's Range | 97.30 - 104.15 |
| 52-Week Range | 94.70 - 123.55 |
| Beta | 0.55 |
About NVSEF
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops,...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Apr 26, 2010
Employees 75,883
Stock Exchange PNK
Ticker Symbol NVSEF
Website https://www.novartis.com